|
Host Cell Proteins
Contamination Kits
Biopharmaceutical
products from recombinant DNA can be contaminated with
components of the host cell system used to manufacture the drug.
Even after multiple purification steps, significant levels of
those impurities can be present. Although low levels of most
contaminants may be inconsequential, patient safety importance
requires that they be eliminated or reduced to the lowest levels
to avoid problems such as adverse immune reactions. Impurities
can have significant cost implications in drug development and
manufacture. Failure to identify and remove these impurities
early in drug development may lead to reduced drug efficacy or
adverse patient reactions that could delay release or kill a
promising drug candidate. Reducing contaminates to very low
levels necessitates multiple purification steps that reduce
product yield.
Recombinant
pharmaceutical products can be contaminated by residual host
cell proteins (HCPs) or other carry over contaminants. It is
essential part of manufacturing of biopharmaceuticals to monitor
these contaminants.
HCPs produced by the host cell during cell
culturing or fermentation can cause an immune response in
patients. Their composition is extremely heterogeneous and
dependent on the protein product and down-stream purification
procedure used. The level of contaminating host cell proteins in
the biopharmaceutical product must be quantitatively measured.
“KRIBIOLISA”
is an effort to provide these tools as aid to the
biopharmaceutical industry after 2 years of in-house product
development. These kits are manufactured by us using
contaminants which are generic in nature.
“KRIBIOLISA”
is the bioprocess contamination products range from us. These
are ELISAs in 96 well format with convenience of break-apart
strips.
Key Features
• Priced competitively; available with shorter lead times & good
product support.
• ELISA with 8 x 12 break-apart strips
• Simple procedural steps for running the Assay.
• Results available within 3 hours hands-on time.
Our Validation Protocols followed are
indicated on a separate page.
For individual kit validation details, please view the kit
insert or ask us for further details.
>>know more

All our kits now
carry the Gold Quality Ring with 5 stars as a mark of our
Quality Assurance. An assurance from us on the quality of our
kits and the vigorous validation and QC protocols they follow
before they are released for sale.
*** coming soon
Bioassays Kits
We offer kits
for complete biological testing as per IP / BP / USP. From
application development and technical system support to complex
biological assays, we offer complete solutions. Biological
assays are a need for compliance of monographs for IP / BP / USP.
With our eight years of experience in biotechnology, we have the
capabilities to provide you or support you with custom made
solutions. For example, a majority of LMW Heparin / Enoxaparin
Sodium manufacturers or formulators use our assay kits for their
regular QC.
We provide assays for hormones, enzymes, cell-based assays for
cancer drugs amongst others. With our offices in US and Europe
we have the capabilities to develop the assays in-house or
source them from companies worldwide. Our current product
portfolio includes assays for -
|
Cat No |
Product Particulars |
Insert |
MSDS |
Pack Size |
| |
|
|
|
|
|
KBBA01 |
Erythropoetin |
 |
 |
48 tests |
|
KBBA02 |
Granulocyte Colony Stimulating Factor (GCSF) |
 |
 |
48 tests |
|
KBBA03 |
Heparin Sodium |
 |
 |
48 tests |
|
KBBA04 |
LMW Heparin Sodium |
 |
 |
100 tests |
|
KBBA05 |
Enoxaparin Sodium |
 |
 |
100 tests |
|
KBBA06 |
Hyaluronidase ** |
 |
 |
96 wells |
|
KBBA07 |
Chymotrypsin ** |
 |
 |
96 wells |
*** coming soon
Immunogenicity Kits
Immunogenicity of Protein Therapeutics
Immunogenicity can have a
number of effects on the therapeutic
outcome of a biologic;
for instance, reduce the efficacy of a
biologic by lowering the molecule’s half-life
in the circulatory system because of rapid clearance by immune
cells or may even lead to generation of auto-antibodies to the
patient’s natural version of that protein. Our assays can be
used for the following purposes:
-
Characterize
isotyping and subtyping of antibodies involved in the
immunogenic response.
-
Generation of
data for specific isotyping and subtyping of antibodies
involved in the immunogenic response.
-
Study of
immunogenic portion of the protein therapeutic
-
To establish
baseline or pretherapy immune response.
Post-launch surveillance of patient population to identify
patients who may generate neutralizing antibodies
|
Cat No |
Product Particulars |
Insert |
MSDS |
Pack Size |
| |
|
|
|
|
|
KBI001 |
Human IgG quantitation ELISA |
 |
 |
96 wells |
|
KBI002 |
Human IgG Isotyping Kit
(IgG1. IgG2, IgG3, IgG4) |
 |
 |
96 wells |
|
KBI003 |
Mouse IgG quantitation ELISA |
 |
 |
96 wells |
|
KBI004 |
Mouse Isotyping ELISA |
 |
 |
96 wells |
|
KBI005 |
Rat IgG quantitation ELISA |
 |
 |
96 wells |
|
KBI006 |
Bovine IgG quantitation
ELISA |
 |
 |
96 wells |
|